Efficacy News and Research

RSS
Singapore hepatitis C therapeutics market revenue to increase to $4.5 billion by 2017

Singapore hepatitis C therapeutics market revenue to increase to $4.5 billion by 2017

'Quit Smoking' Habit Changer program more effective than other popular methods

'Quit Smoking' Habit Changer program more effective than other popular methods

Need for better understanding of appropriate treatment choices for children with insomnia: Study

Need for better understanding of appropriate treatment choices for children with insomnia: Study

Study on interactions between new antitubercular drug candidates SQ109 and TMC207

Study on interactions between new antitubercular drug candidates SQ109 and TMC207

Ampio finalizes negotiations to acquire DMI BioSciences

Ampio finalizes negotiations to acquire DMI BioSciences

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

NIH issues SBIR grant to Titan Pharmaceutical for PD treatment development

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia

Hospira commences EPO Phase I U.S. clinical trial in renal dysfunction patients with anemia

QPS acquires Xendo Drug Development

QPS acquires Xendo Drug Development

Tibotec submits NDA for TMC278 anti-HIV compound to FDA

Tibotec submits NDA for TMC278 anti-HIV compound to FDA

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

Cerenis, Novasep awarded French Government funding for development of CER-001 HDL mimetic

L2FU reports 100% recovery of recent study's lost clinical trial patients

L2FU reports 100% recovery of recent study's lost clinical trial patients

Teva comments on FDA's approval of generic Lovenox injection

Teva comments on FDA's approval of generic Lovenox injection

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

Experimental treatment for sickle cell disease enters Phase 3 clinical trials

AIDS 2010: Obama, Clinton vow U.S. support to global fight against HIV/AIDS

AIDS 2010: Obama, Clinton vow U.S. support to global fight against HIV/AIDS

Einstein scientists awarded $4.1M to test microbicide Carraguard against HPV

Einstein scientists awarded $4.1M to test microbicide Carraguard against HPV

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

Update on Phase III Study of oral calcitonin for treatment of osteoarthritis

Update on Phase III Study of oral calcitonin for treatment of osteoarthritis

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.